## **Core Concept**
The question involves a patient with HIV who has a history of HHV-8 (Human Herpesvirus 8) infection, presenting with a specific leg appearance. HHV-8 is primarily associated with **Kaposi's sarcoma (KS)**, a type of cancer that forms in the lining of blood and lymph vessels. KS is particularly common in immunocompromised individuals, such as those with HIV/AIDS.
## **Why the Correct Answer is Right**
Kaposi's sarcoma caused by HHV-8 in HIV-positive patients often presents with **cutaneous lesions** that can appear as purple, red, or brown patches or nodules on the skin. These lesions are due to the proliferation of spindle cells in the dermis, which form vascular tumors. The lesions can be **painful** and can appear anywhere on the body, including the legs. Given the history of HHV-8 infection and the immunocompromised state of the patient (HIV positive), the appearance of such lesions would strongly suggest Kaposi's sarcoma.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option might represent another dermatological condition but lacks the specificity and classic description of Kaposi's sarcoma lesions.
- **Option B:** Similarly, this could represent a different skin manifestation but does not align with the typical presentation of KS.
- **Option D:** This option might suggest another form of skin lesion or condition not specifically associated with HHV-8 or the typical presentation of Kaposi's sarcoma.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **Kaposi's sarcoma** is one of the **AIDS-defining illnesses**. The presence of KS, especially in an HIV-positive patient with a history of HHV-8 infection, should prompt a thorough evaluation of the patient's immune status and consideration of antiretroviral therapy (ART) initiation or adjustment. KS lesions can be diagnostic, but biopsy confirmation is often necessary.
## **Correct Answer: B.**
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.